Medtronic posts faster growth as cardiac ablation business surges
AI Summary- Medtronic reported faster growth driven by its cardiac ablation business.
- Cardiac ablation growth reached 88% globally and 139% in the U.S.
- Medtronic has increased dividends for 49 consecutive years despite a 20% five-year stock loss.